The estimated Net Worth of Kevin M. Lalande is at least $11.9 Million dollars as of 13 June 2022. Mr. Lalande owns over 222,000 units of Molecular Templates Inc stock worth over $304,140 and over the last 7 years he sold MTEM stock worth over $11,478,000. In addition, he makes $160,552 as Independent Director at Molecular Templates Inc.
Kevin has made over 3 trades of the Molecular Templates Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 222,000 units of MTEM stock worth $197,580 on 13 June 2022.
The largest trade he's ever made was selling 500,000 units of Molecular Templates Inc stock on 16 September 2020 worth over $6,525,000. On average, Kevin trades about 85,167 units every 63 days since 2017. As of 13 June 2022 he still owns at least 222,000 units of Molecular Templates Inc stock.
You can see the complete history of Mr. Lalande stock trades at the bottom of the page.
Kevin M. Lalande serves as Independent Director of the Company. Mr. Lalande served on the board of directors of Private Molecular since 2009. Mr. Lalande is a founder and Managing Director of Santé Ventures, a venture capital firm. Prior to founding Santé Ventures in 2006, Mr. Lalande spent seven years with Austin Ventures. Before joining Austin Ventures, Mr. Lalande was a management consultant with McKinsey & Company. Mr. Lalande holds a B.S. in Electrical and Computer Engineering from Brigham Young University and an M.B.A. with Highest Distinction from the Harvard Business School. Our Board has concluded that Mr. Lalande should serve as a director of the Company based on his substantial experience as a venture capitalist and as a director of a number of privately-held companies.
As the Independent Director of Molecular Templates Inc, the total compensation of Kevin Lalande at Molecular Templates Inc is $160,552. There are 10 executives at Molecular Templates Inc getting paid more, with Eric Poma having the highest compensation of $1,733,740.
Kevin Lalande is 47, he's been the Independent Director of Molecular Templates Inc since 2017. There are 13 older and 6 younger executives at Molecular Templates Inc. The oldest executive at Molecular Templates Inc is David Hoffmann, 75, who is the Independent Director.
Kevin's mailing address filed with the SEC is C/O SANTE VENTURES, 201 WEST 5TH STREET, SUITE 1500, AUSTIN, TX, 78701.
Over the last 7 years, insiders at Molecular Templates Inc have traded over $22,993,582 worth of Molecular Templates Inc stock and bought 14,744,530 units worth $82,519,716 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., David Hirsch und Capital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of $532,718. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth $587,500.
molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.
Molecular Templates Inc executives and other stock owners filed with the SEC include: